Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

Cough syrup deaths: Gambia tightens rules

Cough syrup deaths: Gambia tightens rules

GAMBIA will make it mandatory for all pharmaceutical products from India to be inspected and tested prior to shipment from July 1, according to Gambian government documents reviewed by Reuters, the first known restrictions on national exports following the deaths of dozens of children linked to Indian-made cough syrups. The new rule highlights how governments are reassessing their reliance on India's $42 billion pharmaceutical industry since the contamination came to light last year. India's industry supplies nearly half of the pharmaceuticals used in Africa. In April, India’s government said its officials had held meetings in Africa to ensure its drug…
Read More
‘No confirmation that cough syrup killed 70 children’

‘No confirmation that cough syrup killed 70 children’

GAMBIA has not yet confirmed that toxic cough syrup was the cause of the deaths of 70 children from acute kidney injury, a representative of the country's Medicines Control Agency said. The small West African state has been investigating a mysterious slew of child deaths in recent months, which police said in a preliminary investigation was linked to four cough syrups made in India. World Health Organization (WHO) investigators have found "unacceptable" levels of diethylene glycol and ethylene glycol in the products, which were made by New Delhi-based Maiden Pharmaceuticals Ltd. But Gambia's Medicines Control Agency, a national regulatory body, has not yet pinpointed…
Read More